CD4(+)CD25(+)FOXP3(+) regulatory T cells: a potential “armor” to shield “transplanted allografts” in the war against ischemia reperfusion injury

Despite the advances in therapeutic interventions, solid organ transplantation (SOT) remains the “gold standard” treatment for patients with end-stage organ failure. Recently, vascularized composite allotransplantation (VCA) has reemerged as a feasible treatment option for patients with complex comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyamogan, Shareni, Leventhal, Joseph R., Mathew, James M., Zhang, Zheng Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587564/
https://www.ncbi.nlm.nih.gov/pubmed/37868962
http://dx.doi.org/10.3389/fimmu.2023.1270300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587564/
https://www.ncbi.nlm.nih.gov/pubmed/37868962
http://dx.doi.org/10.3389/fimmu.2023.1270300

Ejemplares similares